Asked what combining the companies would mean for clients in practice, Berlin told AgFunderNews: “We will be synergizing and broadening the business offerings. For instance, customers working on strain development with EG can now gain access to bioprocess development and engineering services under one roof. For way too long strain development has been a bottleneck in this industry with all kind of strings attached. Now with this new offering we can make this critical enabling tool available to the wider biomanufacturing community.”
He added: “Tech transfer from bioprocess developers to engineering teams has been the root cause of many technological failures in the past. By vertically integrating bioprocess development and engineering under one team we minimize or completely eliminate the probability of technological failures. I have witnessed way too many times in my 30+ years of biotech career plant designs that ignored and underplayed the importance of bioprocess particularities.”
Source link
Author Elaine Watson
